Biondi becomes managing partner at Flagship

Paul Biondi has become a managing partner at Flagship Pioneering Inc., which he joined in 2019 as executive partner to start Pioneering Medicines, an internal drug development group created to advance promising but deprioritized assets from across Flagship's platform companies. Biondi became a general partner at the firm last year.

Epitopea Ltd., which is developing RNA-based immunotherapies to treat cancer, hired Klaus Edvardsen as CMO. Edvardsen was chief development officer of Nykode Therapeutics ASA (OSE:NYKD)...